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Angel Porgador,* Jonathan W. Yewdell,² be used to reveal not only the type and location of APCs
but also the phenotype of interacting T cells, includingYuping Deng,² Jack R. Bennink,²
the set of cytokines elicited.and Ronald N. Germain*
The issues of specificity and detection sensitivity that*Lymphocyte Biology Section
are central to the utility of any monoclonal antibodyLaboratory of Immunology
(MAb) are especially critical in the case of MAbs specific²Laboratory of Viral Diseases
for peptide±MHC molecule complexes. Lysis by high-National Institute of Allergy and Infectious
affinity specific T cells can require only a small numberDiseases
(,10±100) of ligands per target (Demotz et al., 1990;National Institutes of Health
Harding and Unanue, 1990; Christinck et al., 1991; Syku-Bethesda, Maryland 20892±1892
lev et al., 1996), each of which also expresses on its
plasma membrane as many as 105 or more identical
MHC molecules associated with hundreds or thousandsSummary
of other peptides (Rudensky et al., 1991; Chicz et al.,
1992; Hunt et al., 1992). Although a few MAbs primarilyCD81 T lymphocytes recognize antigens as short pep-
reacting with particular peptide±MHC class II combina-tides bound to MHC class I molecules. Available meth-
tions have been reported (Aharoni et al., 1991; Murphyods cannot determine the number and distribution of
et al., 1992; Eastman et al., 1996), as a rule antibodiesthese ligands on individual cells or detect antigen-
to MHC molecules do not discriminate among the indi-presenting cells in tissues. Here we describe a method
vidual members of this large population of potential Tfor eliciting and identifying monoclonal antibodies
cell ligands. Some monoclonal anti-MHC class I alloanti-specific for a particular peptide±MHC class I combina-
bodies react with a subset of the molecules encodedtion. One such antibody can identify antigen com-
by a single allele because they are occupied by diverseplexes with a limit of detection approaching that of T
peptides sharing structural features (Bluestone et al.,cells. We used this antibody to determine the number
1992; Catipovic et al., 1992; Hogquist et al., 1993). Al-of peptide±class I complexes generated upon viral in-
though these latter reagents are more selective in theirfection, to identify antigen-presenting cells in cell mix-
reactivity, they are not useful for tracking particular pep-tures, to determine the site of peptide±MHC class I
tide±MHC class I molecule combinations on APCs withinteraction inside cells, and to visualize cells bearing
a physiologically diverse cohort of occupied class I pro-specific peptide±MHC class I complexes after in vivo
teins.
infection. Similar antibodies may prove useful for diag-
Other reported MAbs react with one peptide bound
nostic or therapeutic purposes in cancer, infectious
to an MHC class I molecule but not with at least onediseases, and autoimmune disorders.
other peptide bound to the same MHC class I protein
in tests using class I molecules devoid of endogenously
Introduction processed peptides (Duc et al., 1993; Andersen et al.,
1996). In the former case, analysis with cells displaying a
T lymphocytes do not recognize intact proteins as anti- diverse pool of class I±associated peptides again shows
gens. Instead, their clonally distributed receptors (T cell staining, suggesting substantial reactivity with self-pep-
receptors [TCRs]) interact with ligands composed of tide±associated class I molecules. Because any anti-
short peptides derived from protein antigen and bound body that binds to more than a very small number of
to major histocompatibility (MHC) class Ior class II mole- such self-peptide±MHC class I complexes will be inca-
cules (Yewdell and Bennink, 1990; Germain, 1994). This pable of identifying cells bearingphysiologically relevant
feature of T cell immune recognition has precluded di- (i.e., very low) levels of an antigenic peptide±MHC class
rect tracking of antigen-presenting cells (APCs) in vivo, I combination, this reagent has not proved useful for
because analysis of antigenic protein distribution can- identifying specific antigen complexes. In the latter
not determine whether properly processed peptides de- case, careful tests of reactivity with cells expressing a
rived from this molecule are bound to MHC proteins and broad range of self-peptide complexes have not been
expressed at the surface of the identified cells. Direct reported.
detection of particular peptide±MHC molecule combina- Because of the potential value of MAbs with suitable
tions using flow cytometry or immunohistochemistry specificity for T cell±recognized antigens, we have
would allow quantitation of TCR ligands on individual optimized an immunization and screening strategy that
cells, phenotyping of such APCs, and localization of permits the production and identification of B cell hy-
these APCs within normal or pathologic tissues, while bridomas producing MAbs highly specific for a particu-
confocal immunofluorescence microscopy would per- lar peptide±MHC class I complex. Here we describe
mit analysis of the intracellular site(s) of peptide±MHC the method as well as the detailed characteristics and
molecule interaction and trafficking. In situ localization experimental utility of one such set of MAbs (which we
of APCs bearing particular TCR ligands would be espe- term T-AGs [for T cell AntiGen monoclonal antibodies])
cially valuable in characterizing the cell±cell interactions directed against the extensively studied complex of
involved in initiation, propagation, and maintenance of T H-2Kb bound to the ovalbumin peptide SIINFEKL
(RoÈ tzschke et al., 1991).cell immune responses. Multicolor histochemistry could
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Results
Immunization Approach
To generate MAbs able to detect specific peptide±MHC
class I molecule ligands with minimal binding to class I
molecules bearing other peptides, we designed a
scheme to achieve efficient specific immunization and
to enhance the selectivity of hybridoma screening. Cells
deficient in TAP, the cytosol-to-endoplasmic reticulum
(ER) peptide transporter, can be made to express nearly
homogeneously peptide-loaded surface MHC class I
molecules by incubation with the appropriate synthetic
peptide (Townsend et al., 1989; Schumacher et al.,
1990). On the assumption that cells with a high density
of homogenous peptide±MHC class I complexes would
be effective immunogens for the antibodies we sought,
H-2Kb molecules on TAP-2±deficient RMA-S cells
(Ljunggren and KaÈ rre, 1985; Attaya et al., 1992) were
loaded with synthetic SIINFEKL, corresponding to resi-
dues 257±264 of ovalbumin. Allogeneic mice were im-
munized because syngeneic immunizations, while pre-
venting production of antibodies to the MHC molecule
itself, might fail to induce CD41 T cells important for
effective B cell responses. The sera from mice primed
in this manner showed higher reactivity with H-2Kb cells
loaded with SIINFEKL than with those unexposed to
peptide or loaded with an irrelevant Kb-binding peptide
(vesicular stomatitis virus [VSV] peptide RGYVYQGL,
corresponding to VSV nucleocapsid protein residues
52±59) (Figure 1A). This finding indicated that B cells
producing the desired antibodies were present in these
immunized mice. Splenocytes from boosted animals
were fused with SP2/0 cells by standard techniques,
and supernatants from the resulting hybridomas were
screened by flow cytometry using cells either pulsed
with VSV peptide or with SIINFEKL. Four cultures pro-
ducing antibody binding only to SIINFEKL-pulsed but
not VSV-pulsed RMA-S cells were identified, and three Figure 1. Peptide±MHC Class I Specific Serum Antibody Response
in Immunized Mice andIdentification of Hybridomas Producing SIIN-of these were stably expanded (Figure 1B).
FEKL-Kb Reactive MAb
(A) RMA-S cells pulsed with SIINFEKL or VSV peptides were stainedCategories of Peptide-Dependent
with BALB/c serum (1:100 diluted; ªnaive serumº), serum taken 7Anti-MHC Class I MAbs
days after the third immunization of the mouse later used for fusion
Although each of these MAbs appears to be specific (1:100; ªimmune serumº), Y3 MAb (for total Kb expression; ªtotal
for SIINFEKL-Kb using RMA-S cells, they show different Kbº), or just with second antibody (FITC±rabbit-anti-mouse immuno-
patterns of staining on TAP1 RMA cells versus RMA globulin; ªCont.º). The histograms of SIINFEKL- or VSV peptide±
pulsed RMA-S cells are overlapping except when stained with thecells pulsed with SIINFEKL (Figure 1B). 25-D1 stains
immune serum (arrows).RMA cells only when SIINFEKL is used; it does not stain
(B) Supernatants from approximately 1000 growing fusion wellswereunpulsed or VSV peptide±pulsed RMA. In contrast,
screened for differential staining of RMA-S cells pulsed with SIIN-
22-C5 stains unmanipulated or VSV peptide±pulsed FEKL or VSV peptides. Three positive cultures were stably ex-
RMA to a low but significant extent, in addition to panded: 25-D1 (top), 22-C5 (middle), and 24-C6 (bottom). Left, stain-
strongly staining cells pulsed with SIINFEKL. Finally, ing of RMA-S cells. Right, staining of RMA cells. Nonpulsed cells
(dashed lines), cells pulsed with VSV peptide (dot-dashed lines), or24-C6 shows high staining of untreated RMA or RMA
cells pulsed with SIINFEKL (thick lines) were stained with superna-pulsed with VSV peptide and even greater reactivity with
tant from positive wells. Additional controls: SIINFEKL-pulsed cellsSIINFEKL-pulsed cells, resembling monoclonal alloanti-
stained with Y3 (anti-total Kb, thin lines) or just with second antibodybodies with specificity for a substantial subset of differ-
(FITC±rabbit-anti-mouse immunoglobulin, dotted lines). Total Kb
ent peptide±class I molecule complexes (Bluestone et staining of VSV peptide±pulsed cells (data not shown) was similar
al., 1992; Catipovic et al., 1992; Hogquist et al., 1993). to that of their SIINFEKL-pulsed counterparts. Nonpulsed cells were
Because both 24-C6 and 22-C5 appear to be strictly not tested for staining with 22-C5 in this particular experiment but
were similar to VSV peptide±pulsed cells in other experiments. aKb,specific for SIINFEKL using RMA-S cells, this points
staining with Y3; 1SIINFEKL, cells pulsed with SIINFEKL; 1VSV,out the difficulty of identifying optimally sensitive and
cells pulsed with VSV peptide; 1/2VSV nonpulsed cells or cellsspecific MAbs by screening only with peptide-pulsed
pulsed with VSV peptide.
cells lacking a large cohort of endogenously loaded
MHC class I molecules.
MAb Analysis of Peptide±MHC Class I Complexes
717
Figure 2. Background and SIINFEKL-Spe-
cific Staining Both Require Kb-Expression
(a) L929 (H-2k, gray lines) and L-Kb (H-2k 1
H-2Kb, black lines) cells were pulsed with
SIINFEKL and stained with 25-D1.16 (thin
lines) or isotype control (dotted lines).
(b and c) Surface immunoglobulin±negative
splenocytes from C57Bl/6 (H-2b [b]) and CBA/
J (H-2k [c]) mice, nonpulsed (dotted lines) or
pulsed with SIINFEKL (thin lines), and stained
with 25-D1.16 (black lines) or just second an-
tibody (gray lines).
(d) Splenocytes from naive C57Bl/6 (H-2Kb,
Db; black lines) and B10.A (4R) (H-2Kk, Db; gray
lines) mice were stained with biotinylated 25-
D1.16 (thin lines) or biotinylated control anti-
body (dotted lines) followed by streptavidin-
phycoerythrin.
(e and f) C57Bl/6 mice were inoculated intra-
venously with either 300 mg SIINFEKL (thin
lines) or PBS alone (dotted lines), and 2 hr
later, spleens were harvested for staining with 25-D1.16 (e) or 22-C5.9 (f). Surface immunoglobulin±negative splenocytes were stained with
25-D1.16/22-C5.9 (black lines) or with IgG1, k isotype (gray lines).
(b±f) FcgRII molecules were blocked with 2.4G2; (a±c, e, and f) second antibody was FITC-F(ab9)2 rat anti-mouse IgG.
Affinity and Specificity of 25-D1.16 T cells (Jameson et al., 1993). The Kd of 25-D1.16 for
Kb-SIINFEKL is approximately 7 3 1028 M as determinedSubclones 25-D1.16 (immunoglobulin G1 [IgG1], k) and
22-C5.9 (IgG2a, k) were isolated from 25-D1 and 22-C5, by Scatchard analysis, which is low for antibodies but
substantially higher than measured for most solublerespectively, and their specificities were further ana-
lyzed and compared with T cell recognition (Table 1). TCRs (Matsui et al., 1991; Weber et al., 1992; Corr et
al., 1994; Sykulev et al., 1994; al-Ramadi et al., 1995;25-D1.16 reacts with SIINFEKL-pulsed cells and also
with cells pulsed with V-OVA, which possesses the epi- Alam et al., 1996; Lyons et al., 1996). These specificity
data are also consistent with the ability of 25-D1.16 totopic residues of SIINFEKL and the MHC class I groove-
facing residues of VSV peptide (Fremont et al., 1992; inhibit T cell responses to Kb-SIINFEKL in vitro (data
not shown). 22-C5.9 shows a similar pattern of peptideFremont et al., 1995). Conversely, 25-D1.16 does not
reactwith cells pulsed with VSV peptide, Sendai peptide, binding but also reacts with a position 7 substitution in
SIINFEKL that 25-D1.16 fails to recognize, consistentor variants of SIINFEKL altered at positions known to
affect T cell recognition (Jameson et al., 1993). This with the greater reactivity of 22-C5.9 with endogenous
peptide±Kb complexes on TAP1 cells (Figure 1B).indicates that 25-D1.16 is dependent for its binding on
solvent-exposed residues of Kb-bound SIINFEKL (Fre- Additional experiments were performed to examine
the requirement for H-2Kb in SIINFEKL-dependentmont et al., 1995) and demonstrates the similarity of
recognition by this antibody and SIINFEKL-Kb-specific staining by 25-D1.16 and to detect possible reactivity
Table 1. Comparison of Antibody Staining of and Hybridoma Response to RMA-S Cells Pulsed with SIINFEKL, SIINFEKL Variants, or
Other Kb-Binding Peptides
FACS Staining (Normalized Median)
B3Z-4E4
Peptide Total Kb 25-D1.16 22-C5.9 (Normalized Proliferation)
None 34* 0* 0* 100*
SIINFEKL 100 100 100 2
SIINFPKL (P6) 105 0 0 92
SIINFEDL (D7) 95 0 0 101
SIINFECL (C7) 92 0 44 101
RGYNYEKL (V-OVA) 86 79 84 118
RGYVYQGL (VSV) 93 0 0 91
FAPGNYPAL (Sendai) 101 0 0 98
RMA-S cells were pulsed for 2 hr with 100 mM peptide, washed, and then stained with saturating amounts of 25-D1.16, 22-C5.9, FITC±anti-
mouse H-2Kb, or the appropriate isotypic controls. Second antibody for non±FITC-labeled MAbs was FITC-F(ab9)2 goat anti-mouse-IgG (Fc
fragment). B3Z-4E4 hybridoma cells (Karttunen et al., 1992) were incubated with irradiated (5000 rad) RMA-presenting cells for 20 hr; [3H]thymi-
dine (1 mCi/well) was added at 16 hr for 4 hr; and uptake was measured. Decreased proliferation of the T hybridoma cells indicates TCR
recognition and signaling (Ashwell et al., 1987). Residues underlined in the sequence of V-OVA represent the epitopic residues from SIINFEKL.
* Numbers represent percentage reactivity or response compared to either staining of SIINFEKL-pulsed cells with each antibody or proliferation
of the T hybridoma in the absence of peptide set equal to 100%. Fluorescence medians of the isotypic controls (range 2.5±3) were subtracted
from the medians of staining with the 25-D1.16, 22-C5.9, and the anti-Kb MAbs. Fluorescence medians of SIINFEKL-pulsed RMA-S cells
stained with 25-D1.16, 22-C5.9, and anti-Kb were 77, 67, and 73, respectively. These medians were set equal to 100% and the other medians
normalized accordingly. Incorporated label measured for B3Z-4E4 cells incubated with irradiated nonpulsed RMA-S cells was considered
100% proliferation, and other results were normalized accordingly.
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Figure 3. Detection of SIINFEKL-Kb Com-
plexes Produced by Intracellular Processing
(a and b) EL4 (a) and E.G7-OVA (transfected
EL4 cells producing OVA protein [b]), either
nontreated (gray lines) or pretreated for 36 hr
with murine IFNg [100 U/ml] (black lines),
were stained with 25-D1.16 (thick lines), iso-
type control (dotted lines), or FITC-anti-Kb
(thin lines).
(c) Lipid transfection (lipofection) of OVA pro-
tein: RMA cells were treated with either OVA alone (dotted line), with a mix of OVA and LipofectAMINE (thick line), or with a mix of bovine
serum albumin and LipofectAMINE (dot-dashed line) and stained with 25-D1.16. Staining of OVA-LipofectAMINE treated cells with an isotype
control is also shown (thin line). The percentage of positive cells (M1 marker corrected according to isotype control staining) was 21.5%.
Second antibody for 25-D1.16 and for the isotype control was FITC-F(ab9)2 goat anti-mouse IgG (Fc fragment).
of this antibody with H-2Kb complexed with endogenous the minimal concentrations of SIINFEKL needed to elicit
peptides. L929 cells expressing H-2Kb after gene trans- measurable interleukin-2 (IL-2) secretion by the B3Z-
fer (L-Kb) were stained only after incubation with SIIN- 4E4 T cell hybridoma or IFNg secretion or target cell
FEKL (Figure 2a). The absence of staining of control L lysis by the CD81 CTL line MCW as observed in the
cells lacking expression of H-2Kb but incubated with specific experiment described. Figure 4 also shows the
SIINFEKL formally demonstrates the requirement for this range of minimal concentrations needed to elicit detect-
MHC class I molecule for reactivity with 25-D1.16. In able cytokine secretion or target cell lysis, as measured
contrast to the data obtained with several cultured cell in a variety of published (Reis e Sousa and Germain,
lines, this T-AG shows low but reproducible staining of
splenocytes in the absence of added SIINFEKL; again,
this staining requires Kb expression (Figures 2b±2d). This
appears to represent reactivity with Kb molecules occu-
pied with low-abundance endogenous peptides ex-
pressed on spleen cells but not on the cell lines tested
(A. P. and R. N. G., unpublished data). Despite this low
SIINFEKL-independent staining, 25-D1.16 can identify
specific complexes formed on splenic lymphoid cells
by intravenously administered peptide (Figure 2e). In
contrast, the relatively high background staining of 22-
C5.9 largely obscures the detection of such specific
complexes (Figure 2f).
Detection of Complexes Formed by Active
Intracellular Processing
To examine the ability of 25-D1.16 to detect peptide±
MHC class I complexes produced by physiological anti-
gen processing, we first examined H-2Kb±expressing
EL4 tumor cells or transfected EL4-synthesizing oval-
bumin (E.G7-OVA). Significant staining above control is
clearly seen only with E.G7 (Figures 3a and 3b). Inter-
feron-g (IFNg), which enhances synthesis of class I,
Figure 4. Minimal Concentration of SIINFEKL Peptide Needed forb2-microglobulin (b2m), TAP, and proteasome subunits Detection by 25-D1.16
(David-Watine et al., 1990; Brown et al., 1991; Attaya
RMA cells were pulsed for 2 hr at 378C with titrated amounts of
et al., 1992), increases reactivity of 25-D1.16 with the SIINFEKL (2 pM to 30 mM, 3-fold dilutions), washed, and stained
ovalbumin-producing cells. Endogenously processed with 25-D1.16 followed by FITC-F(ab9)2 goat anti-mouse IgG (Fc
antigen is also detected after lipid introduction of oval- fragment). Results are shown as median of fluorescence intensity
versus peptide concentration. In parallel, pulsed and washed cellsbumin into the cytoplasm (Figure 3c).
were incubated with either B3Z-4E4 or the long-term SIINFEKL-Kb-
specific CD81 CTL line MCW. SIINFEKL concentrations needed toSensitivity of Ligand Detection
elicit minimally detectable amounts of target cell lysis in a 4 hr assayThese data establish the verygreat, though not absolute,
or IFNg secreted by the CTL line MCW or secreted IL-2 by the B3Z-
specificity of 25-D1.16 for SIINFEKL-Kb, as well as its 4E4 hybridoma were 56 pM, 19 pM, and 168 pM, respectively. The
ability to detect naturally processed ovalbumin peptides gray boxes labeled ªIL-2,º ªIFN,º and ªLysisº represent the range
bound to Kb. The staining of ovalbumin-free hematopoi- of peptide concentrations needed for minimally detectable activa-
tion of these T cells in multiple individual experiments conductedetic cells is sufficiently low to suggest that detection of
at various times over a several-month period.specific ligand above this background in vitro might
(Inset) Histograms of RMA cells pulsed with SIINFEKL (19 pM, 14approach the sensitivity of T cells to ligand-induced
nM, and 30 mM) and stained with 25-D1.16. These correspond to
activation through TCRs. To test this idea, 25-D1.16 the points with filled squares in the titration graph. The zero mark
staining was compared over a broad range of peptide labels two control curves: staining of nonpulsed RMA cells with 25-
concentrations to activation of a T hybridoma or a sensi- D1.16 and staining of 19 pM-pulsed RMA cells with isotype control
antibody.tive CTL line (Figure 4). The legend to Figure 4 lists
MAb Analysis of Peptide±MHC Class I Complexes
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Direct Quantitation of Surface Peptide±MHC
Class I Complexes after In
Vitro Viral Infection
A major problem in the field of MHC-dependent antigen
presentation is enumerating specific complexes dis-
played on individual cells produced by endogenous pro-
cessing pathway(s). Only a few studies approaching this
question have appeared in the literature (Falk, et al.,
1991; Malarkannan et al., 1995; AntoÂ n et al., 1997). All
of these studies used peptide elution and antigen pre-
Figure 5. Detection of a Small Population of Cells Bearing Specific
sentation of the eluted peptide in parallel with recon-SIINFEKL-Kb Complexes in a Cell Mixture
struction experiments employing the correspondingEL4 (dotted line), E.G7-OVA (thin line), and a mix (thick line) of EL4
synthetic peptide to estimate the number of complexes(85%) and E.G7-OVA (15%) cells were stained with biotinylated 25-
per cell. These methods are not only extraordinarilyD1.16 followed by streptavidin-phycoerythrin. The calculated per-
centage of E.G7-OVA in the mix is 17% (M1 marker, corrected ac- cumbersome; in addition, they neither distinguish be-
cording to EL4 staining). tween intracellular and cell surface complexes nor deal
with possible heterogeneity in the distribution of com-
plexes among cells in the population, a factor that could
markedly affect the interpretation of the results. In con-1995; Reis e Sousa et al., 1996) and unpublished (C. Reis
trast, T-AGs can readily quantitate the number of celle Sousa et al.) experiments conducted over a several-
surface complexes available to theTCR and can providemonth interval. This allows us to take into account the
information on the distribution of expression of thesevariations in sensitivity to antigen typical of T cells in
complexes on the various cells in a population. Here welong-term culture. This variable sensitivity of T cell de-
use 25-D1.16 to determine the number of Kb-SIINFEKLtection is in striking contrast to the consistent results
complexes formed after recombinant vaccinia virus (rVV)obtained in multiple staining experiments with 25-D1.16,
infection of cells in vitro, in experiments in which thein which a small but reproducible increment of staining
different rVVs express theSIINFEKL sequence in distinctis first seen when cellsare incubated with approximately
contexts.20 pM peptide. The clear difference between staining
Specific 25-D1.16 staining of L-Kb cells is evident fol-of RMA cells pulsed with 19 pM SIINFEKL by 25-D1.16
lowing infection with rVV encoding full-length ovalbuminand by control antibody when displayed as fluorescence
(Figure 6a), a leader-containing SIINFEKL minigene (Fig-histograms is shown in the inset to Figure 4. This con-
ure 6b), a SIINFEKL minigene without a leader (Figurecentration is at the lowest end of the range needed to
6c), or a SIINFEKL minigene with the leader at theelicit IL-2 from a T cell hybridoma and in the midregion
C-terminus (Figure 6d). L-Kb cells infected with a controlof the range of concentrations needed to detect IFNg
virus encoding a leader-VSV Kb-restricted peptide mini-secretion or cytolysis by a CD81 CTL line.
gene (Figure 6e), noninfected L-Kb (Figure 6f), L-Kb
pulsed with the supernatant from the vaccinia stock
encoding the leader-SIINFEKL minigene (Figure 6h), orUse of T-AGs to Detect Rare Cells Bearing
parental L929 cells lacking Kb (Figure 6i) are not specifi-Specific Peptide±MHC Class I Complexes
cally stained. This result demonstrates the absence ofin a Heterogeneous Cell Population
binding of 25-D1.16 to Kb molecules loaded with vac-At present, there are no direct methods available for the
cinia-derived peptides and the absence of SIINFEKL
enumeration and phenotyping of individual cells bearing
peptide in the virus stocks. The percentage and number
physiologic levels of peptide±MHC molecule complexes
in each panel are the calculated percentage of total
in mixed cell populations. T-AGs are ideally suited to
surface Kb occupied by SIINFEKL-Kb and the number
the conduct of such analyses. One important prospec- of SIINFEKL-Kb complexes, respectively (see legend to
tive use of such reagents is in the analysis of tumor Figure 6). The number of complexes detected in even
samples, to help select suitable patients for immuno- the worst case, using rVV-OVA, is more than 3 3 103
therapy and to determine whether residual tumor cells per cell, and with the rVV-minigene reaches 8.5 3 104
have lost expression of the targeted peptide±MHC mole- per cell. In the former case, this number represents 9%
cule combination. To simulate the situation of cells iso- of the expressed Kb, whereas in the latter case more
lated from a tumor biopsy sample in which only a small than 85% of the relevant class I molecules are loaded
fraction might express a low level of tumor-specific anti- with a single peptide species. The latter result is in com-
gen-MHC molecule complexes, we mixed untransfected plete agreement with recent biochemical quantitation
EL4 cells with the E.G7 transfectant of EL4 that synthe- of class I±associated minigene products, in which more
sizes ovalbumin and that has been found to have fewer than 5 3 104 peptides/cell were recovered following
than 100 Kb-SIINFEKL complexes on the plasma mem- infection with rVVs expressing cytosolic or ER-targeted
brane (Malarkannan et al., 1995). Staining with 25-D1.16 Kd or Kk binding peptides (AntoÂ n et al., 1997). The stain-
allows accurate identification of the admixed E.G7 cells ing intensity of the cells infected with the different rVV-
using a simple one-color flow-cytometric analysis (Fig- OVA correlates directly with the reported ability of these
ure 5), demonstrating the ease with which T-AGs can rVVs to prime for SIINFEKL-Kb-specific CTL responses
reveal a cell subpopulation bearing specific endoge- (Restifo et al., 1995). These results clearly demonstrate
the power of such a T-AG to provide useful and easilynously generated peptide±MHC class I complexes.
Immunity
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Figure 6. Detection of SIINFEKL-Kb Com-
plexes on Cells Infected with rVV Expressing
SIINFEKL-Containing Polypeptides
L-Kb cells were infected with rVVs coding
for full-length OVA protein (VV-OVA [a]); an
ER insertion leader-SIINFEKL minigene se-
quence (VV-ES.OVA257±264, [b]); a SIINFEKL
minigene sequence (Met replaces leader)
(VV-OVAM257±264, [c]); a SIINFEKL minigene in
which the leader is at the COOH terminus (VV-
OVAM257±264.ES, [d]); a control rVV containing
the ER insertion leader-VSV peptide minigene
sequence (VV-ES.N257±264 [e]). Additional con-
trols: noninfected L-Kb cells (f); noninfected
and SIINFEKL-pulsed L-Kb (g); L-Kb pulsed
with the supernatant from pelleted rVV-
leader-SIINFEKL minigene (to test for free
peptide in this virus stock) (h); and staining
of parental L929 cells (lacking Kb) (i). After
infection cells were stained with 1 mg (excess)
of either FITC-labeled 25-D1.16 (thick lines),
FITC control for 25-D1.16 (dot-dashed lines),
FITC-anti-total Kb (thin lines), or FITC control
for the Kb antibody (dotted lines). The per-
centages and numbers shown in a±i are the
percentages of total expressed Kb containing
SIINFEKL ([Kb-OVA/total Kb] 3 100) and the
actual calculated numbers of Kb-OVA. FITC-bead standards were used to calculate the number of FITC molecules per cell at the median of
each staining peak. FITC/protein ratios were measured for all of the antibodies at the same time, and number per cell of total Kb and of
SIINFEKL-occupied Kb was calculated. MAbs were all used in excess to ensure monovalent binding. Total Kb expression is suppressed by
rVV infection but the effect varies among different rVVs.
obtained direct quantitative data on specific peptide± demonstrates the presence of Kb-SIINFEKL complexes
in the ER, of which the nuclear membrane is a part.MHC molecule expression on each cell in a population
and the unexpectedly high level of occupancy of MHC Cells infected with an rVV expressing another cytosolic
Kb-binding peptide were not specifically stained, dem-class I molecules attained by determinants derived from
polypeptides produced upon infection by rVVs. onstrating the specificity of T-AG staining (data not
shown). These results are concordant with results from
many of biochemical studies but provide the first visualUse of T-AG 25-D1.16 to Localize the Site
of Intracellular Peptide±MHC evidence of the presence of peptide±class I complexes
in the ER.Class I Interaction
Other aspects of antigen processing and presentation We also used this approach to determine the site of
association of class I molecules with peptides deliveredthat currently can be explored only by indirect and tech-
nically demanding means include the site(s) at which by a amino-terminal signal sequence to the ER of TAP-
deficient cells. This question has yet to be addressed bypeptide and MHC class I molecules interact and the
trafficking of loaded complexes within the cell. Bio- other techniques. Figure 7B reveals that specific T-AG
staining can also be detected in serial sections of thechemical methods addressing these issues rely on the
bulk loading of MHC class I and the stabilization of ER of cells coinfected with rVVs expressing Kb-b2m and
ER-targeted SIINFEKL in the absence of brefeldin A (Fig-the heavy-chain±b2m dimer; although this approach has
been valuable in showing that in the presence but not ure 7B, arrows). Cells were not specifically stained when
either of the components was not included (not shown).absence of TAP, stably assembled class I molecules
are formed in the early secretory pathway, this method These latter results provide the first direct evidence that
loading of peptide not introduced into the ER by TAPpermits neither specific analysis of particular peptide±
MHC class I complexes nor high resolution of the distri- can bind to class I molecules in this organelle.These new
findings have a number of implications for interpretingbution of the complexes. T-AGs are well suited to intra-
cellular staining that circumvents these difficulties. In recent data on the inefficient binding of peptides to class
I molecules not associated with TAP through the tapasinFigure 7A, L929 cells expressing Kb from a transfected
gene were infected with an rVV producing SIINFEKL in molecule (Grandea et al., 1995; Sadasivan et al., 1996)
and for observations showing a failure of class II mole-the cytosol. Postinfection culture was conducted in the
presence of brefeldin A to retain class I complexes in cules to bind TAP-imported peptides in the ER in the
absence of invariant chain.the early secretory pathway. Fixed and permeabilized
cells were indirectly stained with 25-D1.16 and analyzed
with a laser scanning confocal microscope. Four serial In Situ Detection of Cells Bearing Specific
Peptide±MHC Class I Molecule Complexessections taken at 1 mm intervals are shown. Specific
T-AG staining was largely coincident with concanavalin after Viral Infection
Another major potential use of T-AGs is the visualizationA (ConA), which was used to identify the ER. ConA is
able to stain other secretory organelles, but the staining of ligand-bearing cells within undisturbed tissue archi-
tecture using immunohistological methods. As a firstof the nuclear membrane (Figure 7A, arrows) clearly
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Figure 7. Intracellular Localization of Kb-
SIINFEKL Complexes
(A) L929 cells expressing Kb from a
transfected gene were infected for 1 hr with
an rVV expressing cytosolic MSIINFEKL and
then incubated for 4 hr with BFA (5 mg/ml).
Cells were then attached to ConA-coated
coverslips, fixed with 1% paraformaldehyde
for 10 min, and indirectly stained with 25-
D1.16 and rabbit anti-mouse immunoglobulin
conjugated to FITC. The ER was identified by
including rhodamine-conjugated ConA with
the second antibody.
(B) T2 cells infected with rVVs encoding
Kb±b2m and ER-targeted SIINFEKL for 6 hr
were stained and examined as above.
Arrows indicate the inner surface of the nu-
clear membrane.
approach to determining whether 25-D1.16 or similar evidence of vaccinia infection, consistent with the much
lower level of constitutive MHC class I expression byantibodies can be used for such studies, mice were
injected intraperitoneally with the rVV encoding theSIIN- cells in this tissue (data not shown). The 25-D1.16 T-AG
reacts strongly with cells from infected animals in aFEKL minigene or the VSV minigene. Ovaries, the site
of maximal vaccinia virus replication after such virus distribution that also overlaps with part of the strong
class I±staining region, consistent with areas of coinfec-inoculation (Cox et al., 1994), were removed 3 days post-
infection, and frozen sections were reacted with 25- tion of the SIINFEKL minigene recombinant and the Kb 1
b2m recombinant (Figure 8C). No 25-D1.16 staining isD1.16, using various protocols to reveal the T-AG bind-
ing. These experiments showed rare weak positive areas seen in animals coinjected with the Kb 1 b2m recombi-
nant and the control VSV minigene virus (Figure 8F).in the SIINFEKL minigene rVV-injected animals and not
the control VSV minigene rVV-injected mice (data not These data show the ability of the 25-D1.16 antibody to
detect specific peptide±MHC class I complexes in tissueshown). Simultaneous examination for b-galactosidase
(b-gal) produced by the rVV under control of a late viral sections without background. To our knowledge, this is
the first identification of cells bearing a specific peptide±promoter revealed that the b-gal±positive areas were
not overlapping with the rare weak 25-D1.16 positive MHC class I ligand in situ.
areas (data not shown). Simultaneous examination of
total Kb expression and b-gal staining showed that Discussion
b-gal±positive areas were devoid of detectable endoge-
nous Kb expression (data not shown). b-gal±positive ar- We report here a method for producing MAbs specific
for particular peptide±MHC class I complexes (whicheas in rVV-infected ovaries were restricted to the theca
folliculi, a fibroblast layer surrounding the follicle (Fig- we term T-AGs) and describe the exquisite specificity
and utility of one such T-AG in the analysis of MHC classures 8A and 8D). These fibroblasts, when noninfected,
did express Kb (data not shown). Thus, endogenous Kb I antigen processing and presentation in vitro and in
vivo. T-AGs to specific peptide±MHC class II combina-expression by the infected fibroblasts was strongly sup-
pressed by the time b-gal expression could be detected tions have also been generated in this laboratory using
this approach of immunization with cells bearing uni-and T-AG staining performed.
Because of this time-dependent lossof class I expres- formly occupied molecules (G. Zhong et al., unpublished
data). Together, these data indicate that homoge-sion by rVV-infected fibroblasts, along with virus encod-
ing the SIINFEKL minigene or the VSV minigene we coin- neously occupied MHC molecule immunogens may be
especially useful for the elicitation of MAbs with TCR-jected animals with rVV coexpressing the Kb heavy chain
and mouse b2m, to help maintain MHC class I levels. like specificities. TAP-deficient cells expressing various
mouse or human class I alleles exist or can be readilyUnder these conditions, substantial viral replication is
seen in the theca folliculi, as indicated by staining for generated for homogenous peptide loading, and mice
expressing human class I transgenes (Le et al., 1989;b-gal (Figures 8A and 8D). Staining with a pan±anti-Kb
antibody demonstrates that many of the b-gal±positive Vitello et al., 1991) can be immunized to minimize re-
sponses to species- or allele-specific determinants onareas also have high Kb expression (Figures 8B and
8E); such high expression is not seen in areas without peptide±human MHC class I molecule complexes.
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Figure 8. Immunohistochemical Staining of SIINFEKL-Kb Complexes after rVV Infection
C57Bl/6 mice were inoculated intraperitoneally with a 1:1 mix (2 3 107 PFU/mouse) of either VV-Kb 1 b2m and VV-OVAM257±264 (A±C), or VV-
Kb 1 b2m and VV-ES. N257±264 (D±F). All of the rVV also express b-gal from the VV late promoter. Three days later, ovaries were harvested
and serial frozen sections were stained for b-gal activity (A and D), with a pan-H-2Kb MAb (B and E), or with 25-D1.16 (C and F). The same
area in the ovary is shown for either A±C or for D±F and is marked for orientation with white or black asterisks, respectively. Sections shown
in B, C, E, and F are counterstained with hematoxylin.
Our findings demonstrate the critical importance of (1024 to 1026) measured in recent studies for most solu-
ble ab TCRs and their peptide±MHC class I or class IIscreening not just with the target peptide and a random
control peptide capable of binding the same MHC mole- molecule ligands (Matsui et al., 1991; Weber et al., 1992;
Corr et al., 1994; Sykulev et al., 1994; al-Ramadi et al.,cule, but of careful examination of a variety of cell types
with intact processing machinery, to eliminate from con- 1995; Alam et al., 1996; Lyons et al., 1996). On the other
hand, it is in the low range for antibodies reacting withsideration the more frequent antibodies that are peptide
dependent but not sufficiently peptide specific. Even protein ligands, for example, anti-HEL MAb. Without
more examples of MAbs of this type, it is not possiblewith such rigorous screening, it is difficult to prevent
all recognition of endogenous complexes, apparently to know whether this moderate affinity is a necessary
feature of antibodies that show a suitable specificitybecause some such complexes have epitopic residues
so similar to the target complex that any antibody of for particular peptide±MHC molecule combinations. It
seems likely, however, that this would be the case. Anti-useful affinity is likely to show measurable binding. Pro-
vided the representation of such peptides is very small, bodies of substantially greater overall affinity for the
intended target combination might have sufficient resid-approaching the lower limit of ligand display presumed
to function in physiologic T cell activation (Demotz et ual affinity for the MHC molecule itself, or for this mole-
cule occupied by a large range of different peptides, toal., 1990; Harding and Unanue, 1990; Christinck et al.,
1991; Sykulev et al., 1996), sensitive and specific detec- preclude their identification by standard flow-cytometric
approaches in which the dissociation rate of the anti-tion of the target complex over this background can still
be achieved. Excessive binding to endogenous peptides body is too slow to lead to background staining levels
upon routine washing. The fine peptide specificity of thelimits the utility of at least one previously reported MAb
with some specificity for a particular peptide±MHC class 25-D1.16 antibody is similar to that of T cells reactive
with the same SIINFEKL-Kb combination, implying aI complex (Duc et al., 1993). Similar studies with cells
expressing a full cohort of endogenous peptides have somewhat similar ªfootprintº on the complex. If the en-
ergy of association with the MHC molecule per se isnot been reported for a another MAb isolated using
phage display technology (Andersen et al., 1996). inadequate for effective binding and the epitopic resi-
dues of thepeptide make an important positivecontribu-The measured affinity of the 25-D1.16 MAb is approxi-
mately 7 3 1028, similar to the phage-derived antibody tion to affinity, as our data suggest, then it may prove
difficult to raise specific T-AGs against some peptide±to HA255±262-Kk but substantially higher than the values
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MHC molecule combinations if the exposed side chains In the present set of experiments, T-AG 25-D1.16 was
of the peptide cannot provide such an energetic contri- used for quantitation of specific complexes on the cell
bution. surface after infection of cells with rVV encoding the
A crucial feature of T-AGs is their capacity to detect SIINFEKL sequence in a variety of contexts. A single
TCR ligands at cell-surface densities near the threshold experiment taking only 1 day yielded more information
limit for T cell signaling. Other studies in this laboratory on the specific peptide±MHC class I ligand display re-
indicate that the lower limit of sensitivity of our flow sulting from viral infection than in all previously pub-
cytometer is in the range of 300±500 ligands/cell using lished reports on this topic. This analysis demonstrated
single-step staining (Y. Itoh and R. N. G., unpublished that even the least efficient form of antigen synthesized
data), and perhaps 100 ligands per cell with sandwich upon rVV infection (intact ovalbumin) resulted in more
techniques (S. Fleury and R. N. G., unpublished data). than 3 3 103 specific complexes being present on each
These numbers agree with several estimates of the cell membrane, while the most efficient (SIINFEKL mini-
threshold number of peptide±MHC molecule complexes gene) led to a display of more than 8.5 3 104 complexes
needed to elicit nuclear responses from T cells, such per cell. Comparison to total Kb staining showed that in
as cytokine secretion (Demotz et al., 1990; Harding and the latter case, nearly 85% of the Kb molecules were
Unanue, 1990) but are about 10-fold greater than what occupied with a single peptide species. These data
may be required for CTL-mediated cell lysis (Christinck agree with more limited data on the occupancy of class
et al., 1991; Sykulev et al., 1994). Using single-cell popu- I molecules of infected cells with peptides derived from
lations and flow cytometry, it was possible to use the virally encoded proteins. These estimates have been
25-D1.16 antibody to detect specific ligand on cells obtained by analysis of the extent of stabilization of
pulsed with peptide concentrations similar to those newly synthesized class I heavy chain±b2m complexes
needed to activate a T cell hybridoma or CTL line to or elution of peptides from expressed class I molecules
cytokine secretion and within a few fold of the minimal and reconstruction experiments to determine the pep-
concentration able to sensitize target cells for lysis in a tide concentration in the eluates (AntoÂ n et al., 1997).
short-term assay. These data indicate that when applied Although the very high accumulation of specific com-
to dissociated cell populations using flow cytometry, plexes observed using the rVV system with minigene
the detection of ligand with 25-D1.16 approaches the production of optimal peptides may be a special case,
sensitivity of T cells, and hence that this T-AG is a suit- even for the ovalbumin protein rVV, the number of com-
able reagent for evaluating antigenic complex expres- plexes per cell substantially exceeds the remarkably low
sion at low but physiologically relevant levels. number estimated to be needed for triggering already
We have applied this principle here to mixtures of the activated CTL for cytolytic function. This raises the issue
parental EL4 cells and its transfected derivative E.G7. of whether the actual number of specific ligands in-
The latter produces chicken ovalbumin, which is consid-
volved in T cell activation during normal infection in vivo
ered to be a reasonable analog of an oncofetal protein
might be higher than typically thought. We have more
that gives rise to a tumor specific peptide±MHC class I
recently begun to use 25-D1.16 successfully to quanti-
target for immunotherapy present at only 100 copies
tate other aspects of antigen processing, including theper cell (Malarkannan et al., 1995). Even without en-
effects of proteasome inhibitors, the efficiency of vari-hancement of conventional two-step staining for flow
ous transporters in loading class I molecules, and thecytometry, using 25-D1.16 it was possible to readily
biosynthesis of class I molecules in insect cells.identify E.G7 cells admixed with EL4 in low proportion
Another area of investigation in which T-AGs offertosimulate themixed tumor cell population that might be
a clear advantage over existing technology is in thepresent before or after attempts to use antigen-specific
localization of the site(s) of peptide interaction with MHCactive or adoptive antitumor therapy. Correlation of tu-
class I molecules and the trafficking of such complexesmor antigen display on a per-cell and population basis
within cells. Here we have used 25-D1.16 for confocalcould prove especially valuable inevaluating such thera-
immunofluorescence microscopy to assess whetherpies, and T-AGs specific for suitable peptide±human
peptides imported into the ER by TAP versus the translo-HLA class I combinations would be useful tools for stud-
con both bind to class I molecules in that organelle.ies in this area.
Biochemical data supported this view for the TAP-The extreme ease with which precise quantitation of
imported peptides, but no direct data were availablecell surface peptide±MHC complexes can be accom-
concerning the location where peptides accessing theplished using this reagent also make it an invaluable
ER lumen through signal peptide-directed translocontool for antigen processing and presentation studies.
transport metclass I binding sites. This point is not moot,Increasingly, such studies deal with quantitative differ-
since recent studies using human cells with mutationsences in antigen display resulting from use of distinct
within the MHC have identified a novel component offorms of an antigen, of various antigen deliverymethods,
the processing machinery, termed tapasin, the presenceor of cells deficient in some known or suspected compo-
of which seems tobe required for effective peptide load-nent of the processing machinery. Without T-AGs, such
ing and for the production of stable class I heavy chain±quantitation of surface TCR ligand levels relies on bio-
b2m complexes in the ER (Grandea et al., 1995; Sadasi-chemical isolation of antigenic peptides. This is an ex-
van et al., 1996). These data have been interpreted topensive and laborious enterprise subject to numerous
indicate that tethering of nascent class I±b2m complexesexperimental artifacts, which, short of purification of
to TAP via tapasin was required for effective interactionplasma membranes prior to MHC class I extraction, can-
with peptides flowing into the ER lumen via TAP. Thisnot distinguish between intracellular pools of loaded
raises the question of why peptides produced by signalmolecules and those on the cell surface accessible to
TCRs. peptidase cleavage should be able to bind class I in the
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ER in the absence of TAP, if even in its presence the antigen administration to an already autoimmune indi-
failure to colocalize class I as the site of peptide entry vidual and without the loss of function of an entire MHC
precluded effective loading. It was thus important to allele, as would be the case with traditional anti±class
discover that the loading of Kb by SIINFEKL produced by I antibodies. This wide range of basic and applied uses
signal removal after translocon import in TAP-negative seems to ensure vigorous attempts to produce more
cells takes place in the ER itself. This either indicates T-AGs of the type reported here.
that such binding takes place while the newly synthe-
sized class I heavy chain is still in the vicinity of the Experimental Procedures
translocon that also permits entry of the SIINFEKL fusion
Cell Linespeptide, simulating the coupling of TAP peptide import
RMA-S, RMA, and B3Z-4E4 cells were maintained in RPMI 1640and class I held at that site by tapasin, or that the latter
medium with 10% fetal bovine serum. RMA is a Rauscher leukemiamolecule plays a crucial and as yet undiscovered role
virus±induced cell line of C57Bl/6 (H-2b) origin; RMA-S is a mutant
in class I peptide loading distinct from its TAP-binding of this cell with a defect in peptide loading of class I molecules due
function. In related experiments, we have used this MAb to a mutant TAP-2 locus (Ljunggren and KaÈ rre, 1985; Attaya et al.,
to identify the intracellular organelles where exoge- 1992). B3Z-4E4 is a Thybridoma specific for Kb-SIINFEKL (Karttunen
nously added peptides associate with class I molecules, et al., 1992). EL4, E.G7-OVA, and L-Kb cells were maintained in
Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovinea project in which neither biochemical isolation nor T cell
serum. EL4 is a dimethyl-benzanthracene±induced thymoma offunctional assays can be used (P. Day et al., unpublished
C57Bl/6 origin; E.G7-OVA is a transfected clone of EL4-producingdata).
chicken ovalbumin (Moore et al., 1988). L-Kb is an H-2Kb-transfected
Immunohistochemical staining with 25-D1.16 permit- line of L929 cells, expressing Kb in addition to endogneously pro-
ted in situ detection of rVV-infected cells expressing duced Kk and Dk class I molecules (Sheil et al., 1994). The long-
SIINFEKL-Kb complexes. Kb-related background stain- term SIINFEKL-Kb-specific CD81 CTL line MCW was maintained as
ing with 25-D1.16 was not a factor in these conditions described (Reis e Sousa et al., 1996).
because neither noninfected fibroblasts nor cells in-
Peptidesfected with rVV expressing Kb 1 b2m and/or rVV express-
SIINFEKL is chicken ovalbumin peptide 257±264. Control Kb-bindinging VSV peptide were stained. Tosee substantial reactiv-
peptides used in this study are VSV (RGYVYQGL, VSV nucleocapsidity in tissue sections using rVV as an antigen source,
protein 52±59), V-OVA (RGYNYEKL), and Sendai (FAPGNYPAL; Sen-however, we had to coinfect with virus encoding Kb and
dai virus nucleoprotein 324±332). All peptides were synthezied by
b2m. This requirement probably reflects a combination the National Institute of Allergy and Infectious Disease Peptide Syn-
of the lower inherent sensitivity of immunohistochemical thesis Facility using FMOC chemistry and were purified to greater
staining compared to flow-cytometric analysis, the in- than 95% prior to use.
hibitory effects of rVV infection of class I expression,
and the time after virus administration that we are able Immunizations, Fusions, and Hybridoma Screening
RMA-S cells, preincubated at 288C for 24 to 36 hr, were incubatedto analyze the infected tissue. Although this indicates
with 100 mM SIINFEKL in RPMI±25 mM HEPES for 4±6 hr at 378C,that using present technology, these T-AGs have some
irradiated (3000 rad), washed, and injected intraperitonally four timeslimits for tracking APCs in tissue sections, our data nev-
into BALB/c (H-2d) mice at 12±14-day intervals, at 1 3 106 to 5 3
ertheless represent the first visualization of cells in situ 106 cells per inoculation. Sera were harvested from immunized mice
bearing specific peptide±MHC class I complexes and and tested for the presence of antibodies with SIINFEKL-Kb specific-
demonstrate in principle that this approach can be used ity (see below). Mice producing such antibodies were reboosted,
spleens harvested 4 days later, and the splenocytes fused withto conduct such studies for which alternative methods
SP2/0 cells as described (Harlow and Lane, 1988). Growing fusionare not available.
wells were screened by separately staining VSV-pulsed and SIIN-Overall, these experiments provide a new method for
FEKL-pulsed RMA-S with the supernatants from the wells. Of ap-the production of useful MAbs to specific peptide±MHC
proximately 1000 wells with growing hybridomas, 25 had MAbs that
class I complexes. The data obtained with one such recognized both types of peptide±Kb complexes, whereas 4 fusion
MAb (T-AG 25-D1.1.6) shows that such reagents have wells contained MAbs that recognized the SIINFEKL-pulsed but not
obvious utility for flow-cytometric phenotyping of APCs the VSV-pulsed or nonpulsed RMA-S cells. Further screening of the
positive wells was performed with peptide-pulsed RMA cells.isolated from various tissues or organs; for visualizing
the intracellular localization of peptide±MHC com-
Flow Cytometryplexes; for quantitating the number of specific com-
Cells were incubated with primary antibody for 30 min at 48C;plexes formed under various conditions of antigen avail-
washed with phosphate-buffered saline (PBS)±5% fetal calf serum±ability and expression or the function of components of
0.1% sodium azide; and then incubated with a second antibodythe processing and peptide loading machinery within
for 30 min at 48C, washed, and resuspended in the same medium
cells; and perhaps for tracking APCs in vivo. Antibodies plus propidium iodide to exclude dead cells during analysis. Sera
to peptide±human class I complexes present on tumors were used at 1:75 dilution and MAb-containing supernatant at 1:1
(Boon and van der Bruggen, 1996) could potentially be dilution. The second antibody for the sera and for hybridoma screen-
ing was fluorescein isothiocyanate (FITC)±rabbit-anti-mouse immu-used to identify patients whose cells express specific
noglobulin (1:100 dilution, DAKO A/S, Denmark). Stained cells werecomplexes prior to attempting therapeutic vaccination,
analyzed using a FACScan flow cytometer (Becton-Dickinson,to observe vaccinated patients for survival of cells lack-
Mansfield, MA).ing the target antigen, or to target cytotoxic drugs or
radionuclides to the tumor.The ability of such antibodies
Kd Determinationto block TCR recognition of targets suggests that they SIINFEKL (30 mM)±pulsed or nonpulsed RMA cells were incubated
could also be used to decrease disease by interfering for 90 min with titrated amounts of 125I-labeled Fab fragment of 25-
with recognition of normal tissue antigens by autoreac- D1.16. Free and cell-bound 125I were measured after rapid separation
by centrifugation through oil (Coligan et al., 1996). Results weretive CD81 T cells (Wang et al., 1996), without the risk of
MAb Analysis of Peptide±MHC Class I Complexes
725
analyzed using LIGAND software to determine the apparent Kd (Mun- Acknowledgments
Correspondence should be addressed to R. N. G. (e-mail:son and Rodbard, 1980).
Ronald_Germain@nih.gov). We are grateful to Dr. D. H. Margulies
for providing the VSV, Sendai, and C7 peptides, as well as the Y3Lipid Transfection
antibody, and to Dr. J. Sheil for providing L-Kb cells. We also thankFour hundred micrograms of OVA or bovine serum albumin (Sigma,
Dr. Margulies and Dr. C. Reis e Sousa for helpful comments on theSt. Louis, MO) and 30 mg of LipofectAMINE (Life Technologies,
manuscript. We thank Ms. A. Fox for technical assistance. A. P. isGaithersburg, MD) were incubated in 0.2 ml of RPMI±20 mM HEPES
a recipient of a Sara Belk Gambrell fellowship from the Cancer(pH 7.4)±50 mM 2-mercaptoethanol for 15 min and added to 3 3
Research Institute (New York, New York).106 RMA cells suspended in 0.8 ml of the same medium. Cells were
incubated with the lipid±protein mix for 2.5 hr at 378C, washed, and
stained for analysis by flow cytometry. Received December 10, 1996; revised February 19, 1997.
Recombinant Vaccinia Viruses References
The rVVs VV-OVA, VV-ES.OVA257±264, VV-OVAM257±264, VV-OVAM257±264.ES,
and VV-ES.N257±264 used inthis report have been previously described Aharoni, R., Teitelbaum, D., Arnon, R., and Puri, J. (1991). Immuno-
(Restifo et al., 1995). The expression of the antigenic polypeptides modulation of experimental allergic encephalomyelitis by antibodies
is regulated by the VV early/late p7.5 promoter. VV-Kb1 b2m to the antigen-Ia complex. Nature 351, 147±150.
was produced by inserting a cDNA encoding mouse b2m into the Alam, S.M., Travers, P.J., Wung, J.L., Nasholds, W., Redpath, S.,
HindIII±F region of the VV-Kb using the method described by Coupar Jameson, S.C., and Garcoigne, N.R.J. (1996). T-cell-receptor affinity
et al. (1988). b2m is under the control of the VV p7.5 promoter in and thymocyte positive selection. Nature 381, 616±620.
this rVV. All of the rVVs also express b-gal from the VV late promoter.
al-Ramadi, B.K., Jelonek, M.T., Boyd, L.F., Margulies, D.H., andTarget cells (106) were infected with 10 PFU off rVV/cell in 200 ml of
Bothwell, A.L. (1995). Lack of strict correlation of functional sensiti-basal salt solution supplemented with 0.1% (w/v) bovine serum
zation with the apparent affinity of MHC/peptide complexes for thealbumin at 378C. After 1 hr, 1 ml of DMEM±10% fetal calf serum
TCR. J. Immunol. 155, 662±673.was added for an additional 4 hr, and the cells then washed and
Andersen, P.S., Stryhn, A., Hansen, B.E., Fugger, L., Engberg, J.,stained for fluorescence-activated cell sorting. For in vivo infections,
and Buus, S. (1996). A recombinant antibody with the antigen-spe-mice were injected intraperitoneally with 107 PFU of each rVV per
cific, major histocompatibility complex-restricted specificity of Tmouse, and 3 days later, ovaries were harvested for immunohisto-
cells. Proc. Natl. Acad. Sci. USA 93, 1820±1824.chemistry.
AntoÂ n, L.C., Yewdell, J.W., and Bennink, J.R. (1997). MHC class
I-associated peptides produced from endogenous gene productsConfocal Immunofluorescence Analysis
with vastly different efficiencies. J. Immunol., in press.of Intracellular Staining
Ashwell, J.D., Cunningham, R.E., Noguchi, P.D., and Hernandez, D.Cells to be stained were infected with rVV, then attached to ConA-
(1987). Cell growth cycle block of T cell hybridomas upon activationcoated coverslips, fixed with 1% paraformaldehyde for 10 min, and
with antigen. J. Exp. Med. 165, 173±194.indirectly stained with 25-D1.16and rabbit anti-mouse immunoglob-
ulin conjugated to FITC. The ER was identified by including rhoda- Attaya, M., Jameson, S., Martinez, C.K., Hermel, E., Aldrich, C.,
mine-conjugated ConA with the second antibody. Cells wereperme- Forman, J., Lindahl, K.F., Bevan, M.J., and Monaco, J.J. (1992).
abilized by including 0.1% Brij58 in all staining and washing Ham-2 corrects the class I antigen-processing defect in RMA-S
solutions. Serial optical sections were collected using a BioRad cells. Nature 355, 647±649.
MRC1000 laser scanning confocal microscope. Microscope settings Bluestone, J.A., Jameson, S., Miller, S., and Dick, R.D. (1992). Pep-
were adjusted so that black level values were obtained with cells tide-induced conformational changes in class I heavy chains alter
infected with control rVVs. Confocal images were montaged and major histocompatibility complex recognition. J. Exp. Med. 176,
were labeled using Adobe Photoshop software, and prints were 1757±1761.
produced from the digital image using a Fujix Pictography 3000
Boon, T., and van der Bruggen, P. (1996). Human tumor antigensprinter.
recognized by T lymphocytes. J. Exp. Med. 183, 725±729.
Brown, M.G., Driscoll, J., and Monaco, J.J. (1991). Structural and
Immunohistochemistry serological similarity of MHC-linked LMP and proteasome (multica-
Ovaries from infected animals were snap-frozen in liquid nitrogen talytic proteinase) complexes. Nature 353, 355±357.
and stored at 2708C. Frozen sections (5 mM) were cut, mounted on
Catipovic, B., Dal Porto, J., Mage, M., Johansen, T.E., and Schneck,glass slides, and stored at 2708C. For b-gal staining, sections were
J.P. (1992). Major histocompatibility complex conformational epi-fixed in PBS±2% formaldehyde±0.2% glutaraldehyde at 48C for 7
topes are peptide specific. J. Exp. Med. 176, 1611±1618.min, washed in PBS, and incubated with X-Gal substrate (1 mg/
Chicz, R.M., Urban,R.G., Lane, W.S., Gorga, J.C., Stern, L.J., Vignali,ml X-Gal in PBS±5 mM potassium ferricyanide± 5 mM potassium
D.A., and Strominger, J.L. (1992). Predominant naturally processedferrocyanide±2 mM magnesium chloride) at 378C for 10 min. For
peptides bound to HLA-DR1 are derived from MHC-related mole-MAb staining, sections were mildly fixed at 2208C in cold acetone
cules and are heterogeneous in size. Nature 358, 764±768.for 2 min, washed in PBS, and the FcgII and FcgIII receptors ex-
pressed on cells in the tissue blocked with 2.4G2 MAb at 48C for Christinck, E.R., Luscher, M.A., Barber, B.H., and Williams, D.B.
30 min. Biotinylated 25-D1.16 (5 mg/ml final concentration) or biotin- (1991). Peptide binding to class I MHC on living cells andquantitation
ylated AF6±88.5 (5 mg/ml, anti-pan H-2Kb, PharMingen, San Diego, of complexes required for CTL lysis. Nature 352, 67±70.
CA) was added for 40 min at 48C, followed by washing with PBS, Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M., and
incubation with streptavidin-peroxidase at 48C for 30 min, another Strober, W. (1996). Current Protocols in Immunology, Volume 1 (New
PBS wash, and addition of AEC substrate. Strepavidin-peroxidase York: John Wiley and Sons, Inc.).
and AEC were obtained in ready-to-use form in the Histomouse SP
Corr, M., Slanetz, A.E., Boyd, L.F., Jelonek, M.T., Khilko, S., al-kit (Zymed Laboratories, San Francisco, CA). Sections stained with
Ramadi, B.K., Kim, Y.S., Maher, S.E., Bothwell, A.L., and Margulies,MAbs were counterstained with hematoxylin. Stained sections were
D.H. (1994). T cell receptor-MHC class I peptide interactions: affinity,examined using a Zeiss Axioplan microscope and 203 Neuofluor
kinetics, and specificity. Science 265, 946±949.objective. Images were collected with an Optronix ZV5±47E CCD
Coupar, B.E.H., Andrew, M.E., and Boyle, D.B. (1988). A generalcolor video camera and printed with a Sony UP5500 printer. Prints
method for the construction of recombinant vaccinia viruses ex-were digitized using a Hewlett-Packard ScanJet II CX/T flatbed
pressing multiple foreign genes. Gene 68, 1±10.scanner, montaged, and labeled using Adobe Photoshop software.
Prints were produced from the digital image using a Fujix Picto- Cox, J.H., Buller, M.L., Bennink, J.R., Yewdell, J.W., and Karupiah,
G. (1994). Expression of adenovirus E3/19K protein does not altergraphy 3000 printer.
Immunity
726
mouse MHC class I-restricted responses to vaccinia virus. Virology Moore, M.W., Carbone, F.R., and Bevan, M.J. (1988). Introduction
of soluble protein into the class I pathway of antigen processing204, 558±562.
and presentation. Cell 54, 777±785.David-Watine, B., Israel, A., and Kourilsky, P. (1990). The regulation
and expression of MHC class I genes. Immunol. Today 11, 286±292. Munson, P.J., and Rodbard, D. (1980). LIGAND: a versatile compu-
terized approach for characterization of ligand-binding systems.Demotz, S., Grey, H.M., and Sette, A. (1990). The minimal number
Anal. Biochem. 107, 220±239.of class II MHC-antigen complexes needed for T cell activation.
Science 249, 1028±1030. Murphy, D.B., Rath, S., Pizzo, E., Rudensky, A.Y., George, A., Larson,
J.K., and Janeway, C.A. Jr. (1992). Monoclonal antibody detectionDuc, H.T., Rucay, P., Righenzi, S., Halle-Pannenko, O., and Kouril-
of a major self peptide-MHC class-II complex. J. Immunol. 148,sky, P. (1993). Monoclonal antibodies directed against T cell epi-
3483±3491.topes presented by class I MHC antigens. Int. Immunol. 5, 427±431.
Reis e Sousa, C., and Germain, R.N. (1995). Major histocompatibilityEastman, S., Deftos, M., DeRoos, P.C., Hsu, D.H., Teyton, L.,
complex class I presentation of peptides derived from soluble exog-Braunstein, N.S., Hackett, C.J., and Rudensky, A. (1996). A study of
enous antigen by a subset of cells engaged in phagocytosis. J. Exp.complexes of class II invariant chain peptide: major histocompatibil-
Med. 182, 841±851.ity complex class II molecules using a new complex-specific mono-
clonal antibody. Eur. J. Immunol. 26, 385±393. Reis e Sousa, C., Levine, E.H., and Germain, R.N. (1996). Partial
signaling by CD81 T cells in response to antagonist ligands. J. Exp.Falk, K., RoÈ tzschke, O., Deres, K., Metzger, J., Jung, G., and Ram-
Med. 184, 149±157.mensee, H.G. (1991). Identification of naturally processed viral nona-
peptides allows their quantitation in infected cells and suggests an Restifo, N.P., Bacik, I., Irvine, K.R., Yewdell, J.W., McCabe, B.J.,
Anderson, R.W., Eisenlohr, L.C., Rosenberg, S.A., and Bennink, J.R.allele-specific T cell epitope forecast. J. Exp. Med. 174, 425±434.
(1995). Antigen processing in vivo and the elicitation of primary CTLFremont, D.H., Matsumura, M., Stura, E.A., Peterson, P.A., and Wil-
responses. J. Immunol. 154, 4414±4422.son, I.A. (1992). Crystal structures of two viral peptides in complex
with murine MHC class I H-2Kb. Science 257, 919±927. RoÈ tzschke, O., Falk, K., Stevanovic, S., Jung, G., Walden, P., and
Rammensee, H.G. (1991). Exact prediction of a natural Tcell epitope.Fremont, D.H., Stura, E.A., Matsumura, M., Peterson, P.A., and Wil-
Eur. J. Immunol. 21, 2891±2894.son, I.A. (1995). Crystal structure of an H-2Kb-ovalbumin peptide
complex reveals the interplay of primary and secondary anchor Rudensky, A., Preston, H.P., Hong, S.C., Barlow, A., and Janeway,
C.A. Jr. (1991). Sequence analysis of peptides bound to MHC classpositions in the major histocompatibility complex binding groove.
Proc. Natl. Acad. Sci. USA 92, 2479±2483. II molecules. Nature 353, 622±627.
Sadasivan, B., Lehner, P.J., Ortman, B., Spies, T., and Cresswell,Germain, R.N. (1994). MHC-dependent antigen processing and pep-
tide presentation: providing ligands for T lymphocyte activation. Cell P. (1996). Roles of calreticulin and a novel glycoprotein, Tapasin, in
the interaction of MHC class I molecules with TAP. Immunity 5,76, 287±299.
103±114.Grandea, A.G. III, Androlewics, M.J., Athwal, R.S., Geraghty, D.E.,
Spies, T. (1995). Dependence of peptide binding by MHC class I Schumacher, T.N., Heemels, M.T., Neefjes, J.J., Kast, W.M., Melief,
C.J., and Ploegh, H.L. (1990). Direct binding of peptide to emptymolecules on their interaction with TAP. Science 270, 105±108.
MHC class I molecules on intact cells and in vitro. Cell 62, 563±567.Harding, C.V., and Unanue, E.R. (1990). Quantitation of antigen-
presenting cell MHC classII/peptide complexes necessary for T-cell Sheil, J.M., Schell, T.D., Shepherd, S.E., Klimo, G.F., Kioschos,
J.M., and Paterson, Y. (1994). Presentation of a horse cytochromestimulation. Nature 346, 574±576.
c peptide by multiple H-2b class I major histocompatibility complexHarlow, E., and Lane, D. (1988). Antibodies: A Laboratory Manual
(MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lympho-(Cold Spring Harbor: Cold Spring Harbor Laboratory Press).
cytes: presence of a single MHC anchor residue may confer efficientHogquist, K.A., Grandea, A.G. III, and Bevan, M.J. (1993). Peptide
peptide-specific CTL recognition. Eur. J. Immunol. 24, 2141±2149.variants reveal how antibodies recognize major histocompatibility
Sykulev, Y., Brunmark, A., Jackson, M., Cohen, R.J., Peterson, P.A.,complex class I. Eur. J. Immunol. 23, 3028±3036.
and Eisen, H.N. (1994). Kinetics and affinity of reactions betweenHunt, D.F., Henderson, R.A., Shabanowitz, J., Sakaguchi, K., Michel,
an antigen-specific T cell receptor and peptide-MHC complexes.H., Sevilir, N., Cox, A.L., Appella, E., and Engelhard, V.H. (1992).
Immunity 1, 15±22.Characterization of peptides bound to the class I MHC molecule
Sykulev, Y., Joo, M., Vturina, I., Tsomides, T.J., and Eisen, H.N.HLA-A2.1 by mass spectrometry. Science 255, 1261±1263.
(1996). Evidence that a single peptide-MHC complex on a targetJameson, S.C., Carbone, F.R., and Bevan, M.J. (1993). Clone-spe-
cell can elicit a cytolytic T cell response. Immunity 4, 565±571.cific T cell receptor antagonists of major histocompatibility complex
Townsend, A., OÈ hleÂ n, C., Bastin, J., Ljunggren, H.G., Foster, L., andclass I-restricted cytotoxic T cells. J Exp. Med. 177, 1541±1550.
KaÈ rre, K. (1989). Associationof class I major histocompatibility heavyKarttunen, J., Sanderson, S., and Shastri, S. (1992). Detection of
and light chains induced by viral peptides. Nature 340, 443±448.rare antigen-presenting cells by the LacZ T-cell activation assay
Vitello, A., Marchesinin, D., Furze, J., Sherman, L.A., and Chesnut,suggests an expression cloning strategy for T-cell antigens. Proc.
R.W. (1991). Analysis of the HLA-restricted-influenza-specific CTLNatl. Acad. Sci. USA 89, 6020±6024.
response in transgenic mice carrying a chimeric human-mouse classLe, A.X., Bernhard, E.J., Holterman, M.J., Strub, S., Parham, P.,
I MHC. J. Exp. Med. 173, 1007±1015.Lacy, E., and Engelhard, V.H. (1989). Cytotoxic T cell responses
Wang, B., Gonzalez, A., Benoist, C., and Mathis, D. (1996). Thein HLA-A2.1 transgenic mice: recognition of HLA alloantigens and
role of CD81 T cells in the initiation of insulin-dependent diabetesutilization of HLA-A2.1 as a restriction element. J. Immunol. 142,
mellitus. Eur. J. Immunol. 26, 1762±1769.1366±1371.
Weber, S., Traunecker, A., Oliveri, F., Gerhard, W., and Karjalainen,Ljunggren, H.G., and KaÈ rre, K. (1985). Host resistance directed
K. (1992). Specific low-affinity recognition of major histocompatibil-against H-2-deficient lymphoma variants. J. Exp. Med 162, 1745±
ity complex plus peptide by soluble T-cell receptor. Nature 356,1749.
793±796.Lyons, D.S., Lieberman, S.A., Chien, Y., Berg, L.J., and Davis, M.M.
Yewdell, J.W., and Bennink, J.R. (1990). The binary logic of antigen(1996). A TCR binds to antagonist ligands with lower affinities and
processing and presentation to T cells. Cell 62, 203±206.faster dissociation rates than to agonists. Immunity 5, 53±61.
Malarkannan, S., Afkarian, M., and Shastri, N. (1995). A rare cryptic
translation product is presented by Kb MHC class I molecule to
alloreactive T cells. J. Exp. Med. 182, 1739±1750.
Matsui, K., Boniface, J.J., Reay, P.A., Schild, H., Fazekas de St.
Groth, B., and Davis, M.M. (1991). Low affinity interaction of peptide-
MHC complexes with T cell receptors. Science 254, 1788±1791.
